Pediatric Anaplastic Large Cell Lymphoma—A Review
Author:
Affiliation:
1. Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
2. Division of Paediatric Haematology/Oncology, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada
Abstract
Funder
No external funding was received in the publication of this article.
Publisher
Touch Medical Media, Ltd.
Subject
General Medicine
Reference64 articles.
1. Smith MA, Altekruse SF, Adamson PC, et al. Declining childhood and adolescent cancer mortality.Cancer.2014;120:2497–2506.
2. Lowe EJ, Gross TG. Anaplastic large cell lymphoma in children and adolescents.Pediatr Hematol Oncol.2013;30:509–19.
3. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.Blood.1985;66:848–58.
4. Bollard CM, Lim MS, Gross TG, COG Non-Hodgkin Lymphoma Committee. Children’s Oncology Group’s 2013 blueprint for research: non-Hodgkin lymphoma.Pediatr Blood Cancer.2013;60:979–84.
5. Gambacorti-Passerini C, Messa C, Pogliani EM. Crizotinib in anaplastic large-cell lymphoma.N Engl J Med.2011;364:775–6.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma;Pediatric Hematology/Oncology and Immunopathology;2024-04-08
2. Malignancy-Associated Secondary Hemophagocytic Lymphohistiocytosis Mimicking an Infection: A Case Report and Review of the Literature;Cureus;2024-03-22
3. ALK-positive anaplastic large cell lymphoma of paranasal sinuses: two cases report and literature review;Russian Journal of Archive of Pathology;2024
4. Quantitative assessment of minimal residual disease for monitoring of paediatric patients with relapsed/refractory anaplastic large‐cell lymphoma treated with brentuximab vedotin: A case series;British Journal of Haematology;2023-10-11
5. Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature;Clinical Hematology International;2023-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3